Literature DB >> 2534986

Lipid abnormalities in the brain in adult Down's syndrome and Alzheimer's disease.

B W Brooksbank1, M Martinez.   

Abstract

Quantitative analysis by HPTLC of the major lipid classes and dolichol, and of fatty acyl groups of separated phosphoglycerides by capillary GLC, has been carried out on the gray matter of frontal cerebral cortex of brains from six Down's syndrome (DS) and six Alzheimer's disease (AD) adults, and six each of two corresponding sets of age-matched controls; specimens of DS and control cerebellum and corpus callosum were also analyzed. In DS frontal cortex, but not in AD frontal cortex, compared to their respective controls there was a decrease in the fraction of phosphatidylethanolamine (PE) and an increase in the fractions of sphingomyelin (SPM) and phosphatidylserine (PS). Abnormalities were not found in the proportions of major lipid classes in DS cerebellum or corpus callosum. The concentration of dolichol was elevated for age in the frontal cortex of DS and of AD. In the phosphoglycerides of DS frontal cortex, the fatty acyl composition showed small, but statistically significant, differences from those of age-matched controls, and some slight abnormalities were also detected in DS corpus callosum. The alterations in DS frontal cortex included decreases in (n-6) and increases in (n-3) groups in choline and ethanolamine phosphoglycerides (CPG and EPG), as had previously been found in EPG and serine phosphoglyceride (SPG) of the DS fetal brain. In DS frontal cortex, the proportion of 22:4(n-6) groups was decreased in SPG, and in inositol phosphoglyceride (IPG) 18:1(n-9) was increased. There were also small but significant alterations in DS frontal cortex in the fractions of shorter chain groups in CPG. In marked contrast, most of the fatty acyl abnormalities seen in DS were absent in the AD frontal cortex. It is therefore suggested that some abnormalities in the composition of cerebral membranes present prenatally in DS may persist into adulthood, and are not directly related to AD-type pathology.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534986     DOI: 10.1007/bf03160049

Source DB:  PubMed          Journal:  Mol Chem Neuropathol        ISSN: 1044-7393


  14 in total

1.  Amyloid-beta peptide assembly: a critical step in fibrillogenesis and membrane disruption.

Authors:  C M Yip; J McLaurin
Journal:  Biophys J       Date:  2001-03       Impact factor: 4.033

Review 2.  Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases.

Authors:  Rachayeeta Deb; Neha Joshi; Shirisha Nagotu
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

3.  Fatty acid analysis of blood plasma of patients with Alzheimer's disease, other types of dementia, and cognitive impairment.

Authors:  J A Conquer; M C Tierney; J Zecevic; W J Bettger; R H Fisher
Journal:  Lipids       Date:  2000-12       Impact factor: 1.880

4.  Mining functionally relevant gene sets for analyzing physiologically novel clinical expression data.

Authors:  Sevin Turcan; Douglas E Vetter; Jill L Maron; Xintao Wei; Donna K Slonim
Journal:  Pac Symp Biocomput       Date:  2011

Review 5.  Lipid rafts and neurodegeneration: structural and functional roles in physiologic aging and neurodegenerative diseases.

Authors:  Sara Grassi; Paola Giussani; Laura Mauri; Simona Prioni; Sandro Sonnino; Alessandro Prinetti
Journal:  J Lipid Res       Date:  2019-12-23       Impact factor: 5.922

Review 6.  Towards a whole-body systems [multi-organ] lipidomics in Alzheimer's disease.

Authors:  Giuseppe Astarita; Daniele Piomelli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2011-05-04       Impact factor: 4.006

7.  Deficient liver biosynthesis of docosahexaenoic acid correlates with cognitive impairment in Alzheimer's disease.

Authors:  Giuseppe Astarita; Kwang-Mook Jung; Nicole C Berchtold; Vinh Q Nguyen; Daniel L Gillen; Elizabeth Head; Carl W Cotman; Daniele Piomelli
Journal:  PLoS One       Date:  2010-09-08       Impact factor: 3.240

8.  Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease.

Authors:  M Söderberg; C Edlund; K Kristensson; G Dallner
Journal:  Lipids       Date:  1991-06       Impact factor: 1.880

Review 9.  Lipid peroxides in the free radical pathophysiology of brain diseases.

Authors:  A A Farooqui; L A Horrocks
Journal:  Cell Mol Neurobiol       Date:  1998-12       Impact factor: 5.046

10.  Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex.

Authors:  J Farquharson; E C Jamieson; K A Abbasi; W J Patrick; R W Logan; F Cockburn
Journal:  Arch Dis Child       Date:  1995-03       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.